Abstract
Protein citrullination is emerging as an important signaling mechanism that modulates a variety of biological processes. This protein modification constitutes only a 1 Da mass shift, and can be readily confused with other common protein modifications that yield an identical mass shift. In an attempt to develop a robust methodology for detection of protein citrullination sites, we analyzed synthetic citrulline-containing peptides by electrospray ionization tandem mass spectrometry. Collision-induced dissociation (CID) spectra revealed abundant neutral loss of 43 Da from citrullinated peptide precursor ions, which was reconciled by elimination of the HNCO moiety (isocyanic acid) from the citrulline ureido group. The elimination occurs readily in multiple charge states of precursor ions and also in b and y ions. HNCO loss in CID spectra provides a novel diagnostic marker for citrullination, and its utility was demonstrated by the discovery of Arg197 as the specific site of citrullination on nucleophosmin upon peptidylarginine deiminase 4 treatment.
Article PDF
References
György, B.; Tóth, E.; Tarcsa, E.; Falus, A.; Buzás, E. I. Citrullination: A Post-Translational Modification in Health and Disease. Int. J. Biochem. Cell. Biol. 2006, 38, 1662–1677.
Vossenaar, E. R.; Zendman, A. J.; van Venrooij, W. J.; Pruijn, G. J. PAD, a Growing Family of Citrullinating Enzymes: Genes, Features, and Involvement in Disease. Bioessays 2003, 25, 1106–1118.
Wang, Y.; Wysocka, J.; Sayegh, J.; Lee, Y. H.; Perlin, J. R.; Leonelli, L.; Sonbuchner, L. S.; McDonald, C. H.; Cook, R. G.; Dou, Y.; Roeder, R. G.; Clarke, S.; Stallcup, M. R.; Allis, C. D.; Coonrod, S. A. Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination. Science 2004, 306, 279–283.
Li, P.; Yao, H.; Zhang, Z.; Li, M.; Luo, Y.; Thompson, P. R.; Gilmour, D. S.; Wang, Y. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol. Cell. Biol. 2008, 28, 4745–4758.
Chavanas, S.; Méchin, M. C.; Nachat, R.; Adoue, V.; Coudane, F.; Serre, G.; Simon, M. Peptidylarginine Deiminases and Deimination in Biology and Pathology: Relevance to Skin Homeostasis. J. Dermatol. Sci. 2006, 44, 63–72.
Harauz, G.; Musse, A. A. A Tale of Two Citrullines—Structural and Functional Aspects of Myelin Basic Protein Deimination in Health and Disease. Neurochem. Res. 2007, 32, 137–158.
Sebbag, M.; Chapuy-Regaud, S.; Auger, I.; Petit-Texeira, E.; Clavel, C.; Nogueira, L.; Vincent, C.; Cornélis, F.; Roudier, J.; Serre, G. Clinical and Pathophysiological Significance of the Autoimmune Response to Citrullinated Proteins in Rheumatoid Arthritis. Joint Bone Spine 2004, 71, 493–502.
Ishigami, A.; Ohsawa, T.; Hiratsuka, M.; Taguchi, H.; Kobayashi, S.; Saito, Y.; Murayama, S.; Asaga, H.; Toda, T.; Kimura, N.; Maruyama, N. Abnormal Accumulation of Citrullinated Proteins Catalyzed by Peptidylarginine Deiminase in Hippocampal Extracts from Patients with Alzheimer’s Disease. J. Neurosci. Res. 2005, 80, 120–128.
Ishida-Yamamoto, A.; Senshu, T.; Takahashi, H.; Akiyama, K.; Nomura, K.; Iizuka, H. Decreased Deiminated Keratin K1 in Psoriatic Hyperproliferative Epidermis. J. Invest. Dermatol. 2000, 114, 701–705.
Kinloch, A.; Lundberg, K.; Wait, R.; Wegner, N.; Lim, N. H.; Zendman, A. J.; Saxne, T.; Malmstr, V.; Venables, P. J. Synovial Fluid is a Site of Citrullination of Autoantigens in Inflammatory Arthritis. Arthritis Rheum. 2008, 58, 2287–2295.
Suzuki, A.; Yamada, R.; Yamamoto, K. Citrullination by Peptidylarginine Deiminase in Rheumatoid Arthritis. Ann. N.Y. Acad. Sci. 2007, 1108, 323–339.
Szekanecz, Z.; Soós, L.; Szabó, Z.; Fekete, A.; Kapitány, A.; Végvári, A.; Sipka, S.; Szücs, G.; Szántó, S.; Lakos, G. Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?. Clin. Rev. Allergy Immunol. 2008, 34, 26–31.
Raptopoulou, A.; Sidiropoulos, P.; Katsouraki, M.; Boumpas, D. T. Anticitrulline Antibodies in the Diagnosis and Prognosis of Rheumatoid Arthritis: Evolving Concepts. Crit. Rev. Clin. Lab. Sci. 2007, 44, 339–363.
Hagiwara, T.; Hidaka, Y.; Yamada, M. Deimination of Histone H2A and H4 at Arginine 3 in HL-60 Granulocytes. Biochemistry 2005, 44, 5827–5834.
Hagiwara, T.; Nakashima, K.; Hirano, H.; Senshu, T.; Yamada, M. Deimination of Arginine Residues in Nucleophosmin/B23 and Histones in HL-60 Granulocytes. Biochem. Biophys. Res. Commun. 2002, 290, 979–983.
Kidd, B. A.; Ho, P. P.; Sharpe, O.; Zhao, X.; Tomooka, B. H.; Kanter, J. L.; Steinman, L.; Robinson, W. H. Epitope Spreading to Citrullinated Antigens in Mouse Models of Autoimmune Arthritis and Demyelination. Arthritis Res. Ther. 2008, 10, R119 (doi:10.1186/ar2523)..
Nachat, R.; Méchin, M. C.; Takahara, H.; Chavanas, S.; Charveron, M.; Serre, G.; Simon, M. Peptidylarginine Deiminase Isoforms 1–3 are Expressed in the Epidermis and Involved in the Deimination of K1 and Filaggrin. J. Invest. Dermatol. 2005, 124, 384–393.
Kubota, K.; Yoneyama-Takazawa, T.; Ichikawa, K. Determination of Sites Citrullinated by Peptidylarginine Deiminase Using 18O Stable Isotope Labeling and Mass Spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 683–688.
Nakayama-Hamada, M.; Suzuki, A.; Kubota, K.; Takazawa, T.; Ohsaka, M.; Kawaida, R.; Ono, M.; Kasuya, A.; Furukawa, H.; Yamada, R.; Yamamoto, K. Comparison of Enzymatic Properties Between hPADI2 and hPADI4. Biochem. Biophys. Res. Commun. 2005, 327, 192–200.
Palumbo, A. M.; Tepe, J. J.; Reid, G. E. Mechanistic Insights into the Multistage Gas-Phase Fragmentation Behavior of Phosphoserine- and Phosphothreonine-Containing Peptides. J. Proteome Res. 2008, 7, 771–779.
Beausoleil, S. A.; Jedrychowski, M.; Schwartz, D.; Elias, J. E.; Villén, J.; Li, J.; Cohn, M. A.; Cantley, L. C.; Gygi, S. P. Large-Scale Characterization of HeLa Cell Nuclear Phosphoproteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12130–12135.
Brame, C. J.; Moran, M. F.; McBroom-Cerajewski, L. D. A Mass Spectrometry Based Method for Distinguishing Between Symmetrically and Asymmetrically Dimethylated Arginine Residues. Rapid Commun. Mass Spectrom. 2004, 18, 877–881.
Gehrig, P. M.; Hunziker, P. E.; Zahariev, S.; Pongor, S. Fragmentation Pathways of N(G)-Methylated and Unmodified Arginine Residues in Peptides Studied by ESI-MS/MS and MALDI-MS. J. Am. Soc. Mass Spectrom. 2004, 15, 142–149.
Zou, Y.; Wang, Y. Tandem Mass Spectrometry for the Examination of the Post-Translational Modifications of High-Mobility Group A1 Proteins: Symmetric and Asymmetric Dimethylation of Arg25 in HMGA1a Protein. Biochemistry 2005, 44, 6293–6301.
Fischer, G.; Geith, J.; Klapötke, T. M.; Krumm, B. Synthesis, Properties, and Dimerization Study of Isocyanic Acid Z. Naturforschung 2002, 57b, 19–25.
Voorhoeve, R. J.; Trimble, L. E. Synthesis of Isocyanic Acid from Nitric Oxide over Palladium and Iridium Catalysts. Science 1978, 202, 525–526.
Frehlick, L. J.; Eirín-López, J. M.; Ausió, J. New Insights into the Nucleophosmin/Nucleoplasmin Family of Nuclear Chaperones. Bioessays 2007, 29, 49–59.
Hingorani, K.; Szebeni, A.; Olson, M. O. Mapping the Functional Domains of Nucleolar Protein B23. J. Biol. Chem. 2000, 275, 24451–24457.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online December 30, 2008
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Hao, G., Wang, D., Gu, J. et al. Neutral loss of isocyanic acid in peptide CID spectra: A novel diagnostic marker for mass spectrometric identification of protein citrullination. J Am Soc Mass Spectrom 20, 723–727 (2009). https://doi.org/10.1016/j.jasms.2008.12.012
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2008.12.012